APA (7th ed.) Citation

Q, Y., X, P., Y, J., G, R., Z, L., H, L., . . . J, Y. (2021). An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice. Inflammation, 44(5), 1724. https://doi.org/10.1007/s10753-021-01449-4

Chicago Style (17th ed.) Citation

Q, Yin, et al. "An Immuno-blocking Agent Targeting IL-1β and IL-17A Reduces the Lesion of DSS-induced Ulcerative Colitis in Mice." Inflammation 44, no. 5 (2021): 1724. https://doi.org/10.1007/s10753-021-01449-4.

MLA (9th ed.) Citation

Q, Yin, et al. "An Immuno-blocking Agent Targeting IL-1β and IL-17A Reduces the Lesion of DSS-induced Ulcerative Colitis in Mice." Inflammation, vol. 44, no. 5, 2021, p. 1724, https://doi.org/10.1007/s10753-021-01449-4.